Cite
Muszbek N, Evans R, Remak E, et al. Changes in treatment pattern and costs in advanced hepatocellular carcinoma (HCC). Expert Rev Pharmacoecon Outcomes Res. 2021;22(1):147-154doi: 10.1080/14737167.2021.1973892.
Muszbek, N., Evans, R., Remak, E., Brennan, V. K., Colaone, F., Shergill, S., Ross, P., & Mullan, D. (2022). Changes in treatment pattern and costs in advanced hepatocellular carcinoma (HCC). Expert review of pharmacoeconomics & outcomes research, 22(1), 147-154. https://doi.org/10.1080/14737167.2021.1973892
Muszbek, Noemi, et al. "Changes in treatment pattern and costs in advanced hepatocellular carcinoma (HCC)." Expert review of pharmacoeconomics & outcomes research vol. 22,1 (2022): 147-154. doi: https://doi.org/10.1080/14737167.2021.1973892
Muszbek N, Evans R, Remak E, Brennan VK, Colaone F, Shergill S, Ross P, Mullan D. Changes in treatment pattern and costs in advanced hepatocellular carcinoma (HCC). Expert Rev Pharmacoecon Outcomes Res. 2022 Jan;22(1):147-154. doi: 10.1080/14737167.2021.1973892. Epub 2021 Sep 06. PMID: 34488517.
Copy
Download .nbib